Teligent Pre-Tax Profit Margin 2012-2021 | TLGT
Teligent pre-tax profit margin from 2012 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Teligent Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2021-06-30 | $0.05B | $-0.09B | -193.48% |
| 2021-03-31 | $0.05B | $-0.09B | -180.00% |
| 2020-12-31 | $0.05B | $-0.12B | -264.44% |
| 2020-09-30 | $0.05B | $-0.05B | -90.20% |
| 2020-06-30 | $0.06B | $-0.05B | -96.36% |
| 2020-03-31 | $0.06B | $-0.04B | -72.88% |
| 2019-12-31 | $0.07B | $-0.03B | -38.46% |
| 2019-09-30 | $0.07B | $-0.03B | -51.52% |
| 2019-06-30 | $0.07B | $-0.03B | -46.97% |
| 2019-03-31 | $0.06B | $-0.04B | -62.50% |
| 2018-12-31 | $0.07B | $-0.04B | -54.55% |
| 2018-09-30 | $0.06B | $-0.03B | -46.67% |
| 2018-06-30 | $0.05B | $-0.03B | -62.26% |
| 2018-03-31 | $0.06B | $-0.02B | -38.18% |
| 2017-12-31 | $0.06B | $-0.02B | -25.00% |
| 2017-09-30 | $0.06B | $-0.01B | -22.22% |
| 2017-06-30 | $0.07B | $-0.01B | -11.76% |
| 2017-03-31 | $0.07B | $-0.01B | -14.93% |
| 2016-12-31 | $0.06B | $-0.01B | -19.05% |
| 2016-09-30 | $0.06B | $-0.01B | -20.97% |
| 2016-06-30 | $0.06B | $-0.01B | -22.41% |
| 2016-03-31 | $0.05B | $0.00B | -2.00% |
| 2015-12-31 | $0.05B | $0.01B | 15.56% |
| 2015-09-30 | $0.05B | $0.02B | 41.30% |
| 2015-06-30 | $0.04B | $0.02B | 53.66% |
| 2015-03-31 | $0.04B | $0.01B | 34.21% |
| 2014-12-31 | $0.03B | $0.01B | 17.65% |
| 2014-09-30 | $0.03B | 0 | 0.00% |
| 2014-06-30 | $0.02B | 0 | 0.00% |
| 2014-03-31 | $0.02B | 0 | 0.00% |
| 2013-12-31 | $0.02B | 0 | 0.00% |
| 2013-09-30 | $0.01B | $0.00B | -7.14% |
| 2013-06-30 | $0.01B | $0.00B | -16.67% |
| 2013-03-31 | $0.01B | $0.00B | -30.00% |
| 2012-12-31 | $0.01B | $0.00B | -50.00% |
| 2012-09-30 | $0.01B | $0.00B | -50.00% |
| 2012-06-30 | $0.01B | $0.00B | -37.50% |
| 2012-03-31 | $0.01B | $0.00B | -37.50% |
| 2011-12-31 | $0.01B | $0.00B | -37.50% |
| 2011-09-30 | $0.01B | $0.00B | -37.50% |
| 2011-06-30 | $0.01B | $0.00B | -50.00% |
| 2011-03-31 | $0.01B | $0.00B | -50.00% |
| 2010-12-31 | $0.01B | $0.00B | -57.14% |
| 2010-09-30 | $0.01B | $0.00B | -66.67% |
| 2010-06-30 | $0.01B | $0.00B | -80.00% |
| 2010-03-31 | $0.00B | $-0.01B | -125.00% |
| 2009-12-31 | $0.00B | $-0.01B | -125.00% |
| 2009-09-30 | $0.00B | $-0.01B | -125.00% |
| 2009-06-30 | $0.00B | $-0.01B | -125.00% |
| 2009-03-31 | $0.00B | $0.00B | -100.00% |
| 2008-12-31 | $0.01B | $0.00B | -60.00% |
| 2008-09-30 | $0.01B | $0.00B | -33.33% |
| 2008-06-30 | $0.01B | $0.00B | -16.67% |
| 2008-03-31 | $0.01B | 0 | 0.00% |
| 2007-12-31 | $0.01B | 0 | 0.00% |
| 2007-09-30 | $0.00B | $0.00B | -25.00% |
| 2007-06-30 | $0.00B | $0.00B | -25.00% |
| 2007-03-31 | $0.00B | $0.00B | -25.00% |
| 2006-12-31 | $0.00B | $0.00B | -25.00% |
| 2006-09-30 | $0.00B | 0 | 0.00% |
| 2006-06-30 | $0.00B | $0.00B | -25.00% |
| 2006-03-31 | $0.00B | $0.00B | -25.00% |
| 2005-12-31 | $0.00B | $0.00B | -25.00% |
| 2005-09-30 | $0.00B | $0.00B | -25.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2005-03-31 | $0.00B | $0.00B | -25.00% |
| 2004-12-31 | $0.00B | $0.00B | -25.00% |
| 2004-09-30 | $0.00B | $0.00B | -25.00% |
| 2004-06-30 | $0.00B | $0.00B | -25.00% |
| 2004-03-31 | $0.00B | 0 | 0.00% |
| 2003-12-31 | $0.00B | 0 | 0.00% |
| 2003-09-30 | $0.00B | 0 | 0.00% |
| 2003-06-30 | $0.00B | 0 | 0.00% |
| 2003-03-31 | $0.00B | 0 | 0.00% |
| 2002-12-31 | $0.00B | 0 | 0.00% |
| 2002-09-30 | $0.01B | $0.00B | -10.00% |
| 2002-06-30 | $0.01B | $0.00B | -15.38% |
| 2002-03-31 | $0.02B | $0.00B | -12.50% |
| 2001-12-31 | $0.02B | $0.00B | -18.75% |
| 2001-09-30 | $0.02B | $0.00B | -12.50% |
| 2001-06-30 | $0.02B | $0.00B | -18.75% |
| 2001-03-31 | $0.02B | $0.00B | -17.65% |
| 2000-12-31 | $0.02B | $0.00B | -16.67% |
| 2000-09-30 | $0.02B | $0.00B | -21.05% |
| 2000-06-30 | $0.02B | $0.00B | -10.00% |
| 2000-03-31 | $0.02B | $0.00B | -9.52% |
| 1999-12-31 | $0.02B | $0.00B | -4.76% |
| 1999-09-30 | $0.03B | $0.00B | -4.00% |
| 1999-06-30 | $0.03B | $0.00B | -7.14% |
| 1999-03-31 | $0.03B | $0.00B | -13.33% |
| 1998-12-31 | $0.03B | $0.00B | -12.12% |
| 1998-09-30 | $0.03B | $-0.01B | -21.88% |
| 1998-06-30 | $0.03B | $-0.01B | -15.15% |
| 1998-03-31 | $0.03B | $0.00B | -5.88% |
| 1997-12-31 | $0.04B | $0.00B | -2.86% |
| 1997-09-30 | $0.04B | $0.00B | 5.56% |
| 1997-06-30 | $0.04B | $0.00B | 2.86% |
| 1997-03-31 | $0.04B | 0 | 0.00% |
| 1996-12-31 | $0.04B | $0.00B | -2.86% |
| 1996-09-30 | $0.03B | 0 | 0.00% |
| 1996-06-30 | $0.03B | 0 | 0.00% |
| 1996-03-31 | $0.03B | $0.00B | 3.03% |
| 1995-12-31 | $0.03B | $0.00B | 6.45% |
| 1995-09-30 | $0.03B | $0.00B | 9.68% |
| 1995-06-30 | $0.03B | $0.00B | 13.33% |
| 1995-03-31 | $0.03B | $0.00B | 13.79% |
| 1994-12-31 | $0.03B | $0.00B | 10.34% |
| 1994-09-30 | $0.03B | $0.01B | 17.86% |
| 1994-06-30 | $0.03B | $0.00B | 14.29% |
| 1994-03-31 | $0.03B | $0.00B | 10.71% |
| 1993-12-31 | $0.03B | $0.00B | 10.71% |
| 1993-09-30 | $0.03B | 0 | 0.00% |
| 1993-06-30 | $0.03B | 0 | 0.00% |
| 1993-03-31 | $0.03B | 0 | 0.00% |
| 1992-12-31 | $0.02B | 0 | 0.00% |
| 1992-09-30 | $0.02B | 0 | 0.00% |
| 1992-06-30 | $0.02B | 0 | 0.00% |
| 1992-03-31 | $0.02B | 0 | 0.00% |
| 1991-12-31 | $0.02B | 0 | 0.00% |
| 1991-09-30 | $0.02B | 0 | 0.00% |
| 1991-06-30 | $0.02B | 0 | 0.00% |
| 1991-03-31 | $0.02B | 0 | 0.00% |
| 1990-12-31 | $0.02B | 0 | 0.00% |
| 1990-09-30 | $0.02B | 0 | 0.00% |
| 1990-06-30 | $0.02B | 0 | 0.00% |
| 1990-03-31 | $0.02B | 0 | 0.00% |
| 1989-12-31 | $0.02B | 0 | 0.00% |
| 1989-09-30 | $0.02B | 0 | 0.00% |
| 1989-06-30 | $0.02B | 0 | 0.00% |
| 1989-03-31 | $0.02B | 0 | 0.00% |
| 1988-12-31 | $0.02B | 0 | 0.00% |
| 1988-09-30 | $0.02B | $0.00B | 6.25% |
| 1988-06-30 | $0.02B | $0.00B | 6.25% |
| 1988-03-31 | $0.02B | $0.00B | 6.25% |
| 1987-12-31 | $0.02B | $0.00B | 6.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |